Literature DB >> 19084852

Is it necessary to remove the seminal vesicles completely at radical prostatectomy? decision curve analysis of European Society of Urologic Oncology criteria.

Fernando P Secin1, Fernando J Bianco, Angel Cronin, James A Eastham, Peter T Scardino, Bertrand Guillonneau, Andrew J Vickers.   

Abstract

PURPOSE: A publication on behalf of the European Society of Urological Oncology questioned the need for removing the seminal vesicles during radical prostatectomy in patients with prostate specific antigen less than 10 ng/ml except when biopsy Gleason score is greater than 6 or there are greater than 50% positive biopsy cores. We applied the European Society of Urological Oncology algorithm to an independent data set to determine its predictive value.
MATERIALS AND METHODS: Data on 1,406 men who underwent radical prostatectomy and seminal vesicle removal between 1998 and 2004 were analyzed. Patients with and without seminal vesicle invasion were classified as positive or negative according to the European Society of Urological Oncology algorithm.
RESULTS: Of 90 cases with seminal vesicle invasion 81 (6.4%) were positive for 90% sensitivity, while 656 of 1,316 without seminal vesicle invasion were negative for 50% specificity. The negative predictive value was 98.6%. In decision analytic terms if the loss in health when seminal vesicles are invaded and not completely removed is considered at least 75 times greater than when removing them unnecessarily, the algorithm proposed by the European Society of Urological Oncology should not be used.
CONCLUSIONS: Whether to use the European Society of Urological Oncology algorithm depends not only on its accuracy, but also on the relative clinical consequences of false-positive and false-negative results. Our threshold of 75 is an intermediate value that is difficult to interpret, given uncertainties about the benefit of seminal vesicle sparing and harm associated with untreated seminal vesicle invasion. We recommend more formal decision analysis to determine the clinical value of the European Society of Urological Oncology algorithm.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19084852      PMCID: PMC2777757          DOI: 10.1016/j.juro.2008.10.035

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  16 in total

1.  Seminal vesicle-sparing radical prostatectomy: a novel concept to restore early urinary continence.

Authors:  H John; D Hauri
Journal:  Urology       Date:  2000-06       Impact factor: 2.649

Review 2.  Localized prostate cancer.

Authors:  Makoto Ohori; Peter T Scardino
Journal:  Curr Probl Surg       Date:  2002-09       Impact factor: 1.909

3.  Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis on 1283 patients.

Authors:  Alexandre R Zlotta; Thierry Roumeguère; Vincent Ravery; Paul Hoffmann; Francesco Montorsi; Levent Türkeri; Michael Dobrovrits; Vincenzo Scattoni; Samuel Ekane; Renaud Bollens; Marc Vanden Bossche; Bob Djavan; Laurent Boccon-Gibod; Claude C Schulman
Journal:  Eur Urol       Date:  2004-07       Impact factor: 20.096

4.  Complete resection of seminal vesicles at radical prostatectomy results in substantial long-term disease-free survival: multi-institutional study of 6740 patients.

Authors:  Angelo Baccala; Alwyn M Reuther; Fernando J Bianco; Peter T Scardino; Michael W Kattan; Eric A Klein
Journal:  Urology       Date:  2007-03       Impact factor: 2.649

5.  Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy.

Authors:  Fernando P Secin; Fernando J Bianco; Andrew J Vickers; Victor Reuter; Thomas Wheeler; Paul A Fearn; James A Eastham; Peter T Scardino
Journal:  Cancer       Date:  2006-06-01       Impact factor: 6.860

6.  The palpable nodule of prostatic cancer. Results 15 years after radical excision.

Authors:  H J Jewett; R W Bridge; G F Gray; W M Shelley
Journal:  JAMA       Date:  1968-02-05       Impact factor: 56.272

7.  Prostate-specific antigen expression and lipochrome pigment granules in the differential diagnosis of prostatic adenocarcinoma versus seminal vesicle-ejaculatory duct epithelium.

Authors:  V B Shidham; P F Lindholm; A Kajdacsy-Balla; Z Basir; V George; F U Garcia
Journal:  Arch Pathol Lab Med       Date:  1999-11       Impact factor: 5.534

8.  Decision curve analysis: a novel method for evaluating prediction models.

Authors:  Andrew J Vickers; Elena B Elkin
Journal:  Med Decis Making       Date:  2006 Nov-Dec       Impact factor: 2.583

9.  Seminal vesicle-sparing perineal radical prostatectomy improves early functional results in patients with low-risk prostate cancer.

Authors:  Peter Albers; Sebastian Schäfers; Hans Löhmer; Patrick de Geeter
Journal:  BJU Int       Date:  2007-08-30       Impact factor: 5.588

10.  Prostate cancer radiotherapy dose response: an update of the fox chase experience.

Authors:  Alan Pollack; Alexandra L Hanlon; Eric M Horwitz; Steven J Feigenberg; Robert G Uzzo; Gerald E Hanks
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

View more
  5 in total

1.  Prostate cancer: seminal vesicle sparing: a continuing trend?

Authors:  Scott M Gilbert
Journal:  Nat Rev Urol       Date:  2009-09       Impact factor: 14.432

2.  Assessing the Clinical Impact of Risk Prediction Models With Decision Curves: Guidance for Correct Interpretation and Appropriate Use.

Authors:  Kathleen F Kerr; Marshall D Brown; Kehao Zhu; Holly Janes
Journal:  J Clin Oncol       Date:  2016-05-31       Impact factor: 44.544

3.  Assessing the Clinical Impact of Risk Models for Opting Out of Treatment.

Authors:  Kathleen F Kerr; Marshall D Brown; Tracey L Marsh; Holly Janes
Journal:  Med Decis Making       Date:  2019-01-16       Impact factor: 2.583

4.  Continence rate and oncological feasibility after total transurethral resection of the prostate as an alternative therapy for the treatment of prostate cancer: a pilot study.

Authors:  Hee Jong Jeong; Dong Deuk Kwon
Journal:  Int Neurourol J       Date:  2011-12-31       Impact factor: 2.835

5.  Predicting the occurrence of multidrug-resistant organism colonization or infection in ICU patients: development and validation of a novel multivariate prediction model.

Authors:  Li Wang; Xiaolong Huang; Jiating Zhou; Yajing Wang; Weizhang Zhong; Qing Yu; Weiping Wang; Zhiqiao Ye; Qiaoyan Lin; Xing Hong; Ping Zeng; Minwei Zhang
Journal:  Antimicrob Resist Infect Control       Date:  2020-05-19       Impact factor: 4.887

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.